Euro strengthens against Japanese Yen ahead of Eurozone HICP inflation data
EUR/JPY rises after a flat previous day, trading around 186.00 during the early European hours on Tuesday. The Euro gains ground against the Japanese Yen (JPY) as traders increasingly price in a hawkish stance from the European Central Bank (ECB), driving the currency cross higher ahead of crucial economic data.
Market participants are bracing for the preliminary Harmonized Index of Consumer Prices (HICP) reading from the Eurozone due later on Tuesday, which is expected to offer vital clues regarding the ECB's interest rate outlook. Headline inflation is projected to tick up to 3.2% YoY in May from 3.0% in April, and any signs of hotter-than-expected inflation could provide the shared currency with a near-term boost.
ECB Executive Board member Isabel Schnabel delivered hawkish remarks on Monday, signaling a potential need for further rate hikes. Schnabel warned that the central bank can no longer overlook the inflationary impact of the conflict in Iran, noting that price pressures have spread well beyond the energy sector and heightened the risk of unanchored inflation expectations.
Meanwhile, the Japanese Yen (JPY) continued its slide on Tuesday, weakening beyond 159.5 per US Dollar (USD). This downward move brings the currency dangerously close to the critical 160 threshold, the exact level that previously triggered direct market intervention from Japanese officials to support the domestic currency, which could limit the upside of the EUR/JPY cross.
Japan’s Finance Minister Satsuki Katayama addressed the JPY's depreciation on Tuesday, stating that persistent volatility in the oil markets remains a concern and that authorities stand ready to take suitable measures if necessary. While Katayama confirmed that ministry officials are in close communication with their counterparts in Washington regarding foreign exchange developments, she ultimately declined to comment on whether a direct currency intervention is imminent.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Voices of doubt arise, Moderna CEO reassures the market: Personalized cancer vaccines will cover more types of cancer
Moderna's CEO is highly confident about the prospects of the personalized mRNA cancer vaccine intismeran autogene, stating that it will play a role in more cancers beyond melanoma and drawing parallels with Merck's blockbuster drug Keytruda. Jefferies warns that cross-indication replication is still inconclusive; Citi maintains a "sell" rating, pointing out that commercial application remains limited, with critical issues such as patient suitability, manufacturing, and overall survival data yet to be addressed.
Morgan Stanley Declares U.S. Stock Market Correction Nears End! Maintains Year-End S&P 8000 Target, Identifies Three Major Rebound Catalysts
As Morgan Stanley remains bullish on the stock market, recent market trends have precisely demonstrated the strong rebound momentum of tech stocks dominated by the semiconductor sector. The Philadelphia Semiconductor Index rose by 0.44% on October 23rd and further increased by 2.82% on the 26th.
Eight Highlights of Anthropic IPO Prospectus: Astonishing Growth, but Risks are Obvious
The Anthropic prospectus reveals several highlights: a large-scale enterprise customer base with over 1,900 customers generating more than one million dollars in revenue; as of June 2026, revenue has increased by 1,368% year over year, far surpassing the growth rate of computing costs; positive operating cash flow; and all seven co-founders remain with the company. The company also acknowledges risks, including concentrated supply from TSMC and potential memory chip shortages as significant concerns. October ARR data will be additionally disclosed in a revised version of the document.
Selling Chips, Leasing, Providing Residual Value Support: Broadcom (AVGO.US) Teams Up with Wall Street's Four Giants to Raise $63 Billion to "Inject Funds" for Anthropic's Chip Procurement
Broadcom has reached a $63 billion deal with Bank of America, Blackstone Group, Citigroup, and Morgan Stanley to provide funding for the purchase of chips for AI model developer Anthropic PBC. The transaction is conducted through a newly established special purpose company, which has secured financial commitments from these firms to purchase Broadcom chips and lease them to Anthropic.
Crypto prices
More
